HANUMANTHA PULIVARTHI to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications HANUMANTHA PULIVARTHI has written about Xenograft Model Antitumor Assays.
Connection Strength
0.107
-
A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010 Jun; 12(6):580-94.
Score: 0.063
-
TP53 loss creates therapeutic vulnerability in?colorectal cancer. Nature. 2015 Apr 30; 520(7549):697-701.
Score: 0.022
-
Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLoS One. 2014; 9(8):e106249.
Score: 0.021